News
AVAH
12.32
+9.12%
1.03
Aveanna price target raised to $13 from $8 at UBS
TipRanks · 1h ago
Aveanna Healthcare (AVAH) Stock Climbs On Higher Guidance And Cash Flow
Simply Wall St · 1d ago
Aveanna Healthcare Price Target Raised to $13.00/Share From $8.00 by UBS
Dow Jones · 1d ago
Aveanna Healthcare Is Maintained at Neutral by UBS
Dow Jones · 1d ago
UBS Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $13
Benzinga · 1d ago
Aveanna Healthcare Is Maintained at Strong Buy by Raymond James
Dow Jones · 1d ago
Aveanna Healthcare Price Target Raised to $15.00/Share From $13.00 by Raymond James
Dow Jones · 1d ago
Raymond James Maintains Strong Buy on Aveanna Healthcare Hldgs, Raises Price Target to $15
Benzinga · 1d ago
UBS Releases a Hold Rating on Aveanna Healthcare Holdings (AVAH)
TipRanks · 2d ago
Aveanna Healthcare Price Target Raised to $14.00/Share From $10.00 by BMO Capital
Dow Jones · 2d ago
Aveanna Healthcare Is Maintained at Outperform by BMO Capital
Dow Jones · 2d ago
Aveanna Healthcare Holdings (AVAH) Receives a Buy from Deutsche Bank
TipRanks · 2d ago
BMO Capital Maintains Outperform on Aveanna Healthcare Hldgs, Raises Price Target to $14
Benzinga · 2d ago
AVAH Crosses Above Average Analyst Target
NASDAQ · 2d ago
Analysts Offer Insights on Healthcare Companies: Nektar Therapeutics (NKTR), Aveanna Healthcare Holdings (AVAH) and GoodRx Holdings (GDRX)
TipRanks · 2d ago
Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Caribou Biosciences (CRBU) and Aveanna Healthcare Holdings (AVAH)
TipRanks · 2d ago
Barclays Keeps Their Buy Rating on Aveanna Healthcare Holdings (AVAH)
TipRanks · 2d ago
Biotech Stocks At 52-Week Highs - PARK +10%, AVAH +24%, CADL +10% On Q2 Reports, LH, COAG
NASDAQ · 2d ago
Aveanna hits 52-week high after Q2 beat, guidance hike
Seeking Alpha · 2d ago
Aveanna Healthcare: Q2 Earnings Report Boosts The Stock And Reinforces My Buy Rating
Seeking Alpha · 2d ago
More
Webull provides a variety of real-time AVAH stock news. You can receive the latest news about Aveanna Healthcare Holdings, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About AVAH
Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. The Company's segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. The HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. The Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The MS business serves patients who have short or long-term disabilities and require a supply of infant, pediatric and adult formulas.